These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31648389)

  • 1. Establishment and characterization of a novel neuroendocrine carcinoma cell line derived from a human ascending colon tumor.
    Shinji S; Sasaki N; Yamada T; Koizumi M; Ohta R; Matsuda A; Yokoyama Y; Takahashi G; Hotta M; Hara K; Takeda K; Ueda K; Kuriyama S; Ishiwata T; Ueda Y; Murakami T; Kanazawa Y; Yoshida H
    Cancer Sci; 2019 Dec; 110(12):3708-3717. PubMed ID: 31648389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin.
    Soliman ML; Tiwari A; Zhao Q
    World J Gastroenterol; 2017 Feb; 23(6):1106-1112. PubMed ID: 28246485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line.
    Gock M; Mullins CS; Harnack C; Prall F; Ramer R; Göder A; Krämer OH; Klar E; Linnebacher M
    World J Gastroenterol; 2018 Sep; 24(33):3749-3759. PubMed ID: 30197480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer.
    Ogimi T; Sadahiro S; Kamei Y; Chan LF; Miyakita H; Saito G; Okada K; Suzuki T; Kajiwara H
    Oncology; 2019; 97(5):294-300. PubMed ID: 31390635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Poorly-differentiated neuroendocrine carcinoma of ascending colon with liver metastases successfully treated with carboplatin and etoposide].
    Akiyama S; Niitani T; Narasaka T; Ohto T; Gamoh M
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1209-12. PubMed ID: 21772114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Neuroendocrine Carcinoma of the Ascending Colon That Responded Completely to Chemotherapy].
    Satake M; Yoshimatsu K; Ito Y; Imaizumi R; Sano M; Kodera A; Miyano Y; Koike T; Yamada Y; Okayama S; Yokomizo H; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1513-1515. PubMed ID: 30382062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
    Lin HH; Chang CC; Yang SH; Chang SC; Chen WS; Liang WY; Lin JK; Jiang JK
    World J Surg Oncol; 2016 Mar; 14():84. PubMed ID: 26976278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and Characterization of a Novel Cell Line Derived from a Small Cell Neuroendocrine Carcinoma of the Anal Canal.
    Dizdar L; Drusenheimer J; Werner TA; Möhlendick B; Schütte SC; Esposito I; Filler TJ; Knoefel WT; Krieg A
    Neuroendocrinology; 2018; 107(3):246-256. PubMed ID: 30025411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effective chemotherapy with bevacizumab/FOLFOX4 for neuroendocrine carcinoma of the ascending colon - a case study].
    Tanabe H; Takase T; Morimoto D; Tanaka Y; Shibata A; Yaguchi T
    Gan To Kagaku Ryoho; 2014 May; 41(5):661-4. PubMed ID: 24917018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon.
    Kato T; Terashima T; Tomida S; Yamaguchi T; Kawamura H; Kimura N; Ohtani H
    Pathol Int; 2005 Aug; 55(8):524-9. PubMed ID: 15998383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New model for gastroenteropancreatic large-cell neuroendocrine carcinoma: establishment of two clinically relevant cell lines.
    Krieg A; Mersch S; Boeck I; Dizdar L; Weihe E; Hilal Z; Krausch M; Möhlendick B; Topp SA; Piekorz RP; Huckenbeck W; Stoecklein NH; Anlauf M; Knoefel WT
    PLoS One; 2014; 9(2):e88713. PubMed ID: 24551139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
    Bruera G; Giuliani A; Romano L; Chiominto A; Di Sibio A; Mastropietro S; Cosenza P; Ricevuto E; Schietroma M; Carlei F;
    BMC Cancer; 2019 Oct; 19(1):960. PubMed ID: 31619203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic
    Capdevila J; Arqués O; Hernández Mora JR; Matito J; Caratù G; Mancuso FM; Landolfi S; Barriuso J; Jimenez-Fonseca P; Lopez Lopez C; Garcia-Carbonero R; Hernando J; Matos I; Paolo N; Hernández-Losa J; Esteller M; Martínez-Cardús A; Tabernero J; Vivancos A; Palmer HG
    Clin Cancer Res; 2020 Feb; 26(4):902-909. PubMed ID: 31672771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Helpap B
    Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
    Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
    Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis.
    Mia-Jan K; Munkhdelger J; Lee MR; Ji SY; Kang TY; Choi E; Cho MY
    Tohoku J Exp Med; 2013 Apr; 229(4):301-9. PubMed ID: 23615455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of an ascending colon mixed adenoneuroendocrine carcinoma with clinical serosal invasion.
    Liu XJ; Feng JS; Xiang WY; Kong B; Wang LM; Zeng JC; Liang YF
    Int J Clin Exp Pathol; 2014; 7(9):6395-8. PubMed ID: 25337298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Case of a Long-Surviving Patient with Colorectal Neuroendocrine Carcinoma with Invasion of the Jejunum and Lymph Node Metastases after Operation].
    Kobayashi H; Koizumi N; Takagi T; Fukumoto K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2218-20. PubMed ID: 26805316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.